Citation

Ishitsuka Y, Kondo Y, Kadowaki D. Biol. Pharm. Bull. 2020; 43(2): 195-206.

Affiliation

Department of Clinical Pharmaceutics, Faculty of Pharmaceutical Sciences, Sojo University.

Copyright

(Copyright © 2020, Pharmaceutical Society of Japan)

DOI

10.1248/bpb.b19-00722

PMID

32009106

Abstract

Acetaminophen (paracetamol, N-acetyl-p-aminophenol; APAP) is the most popular analgesic/antipyretic agent in the world. APAP has been regarded as a safer drug compared with non-steroidal anti-inflammatory drugs (NSAIDs) particularly in terms of lower risks of renal dysfunction, gastrointestinal injury, and asthma/bronchospasm induction, even in high-risk patients such as the elderly, children, and pregnant women. On the other hand, the recent increasing use of APAP has raised concerns about its toxicity. In this article, we review recent pharmacological and toxicological findings about APAP from basic, clinical, and epidemiological studies, including spontaneous drug adverse events reporting system, especially focusing on drug-induced asthma and pre-and post-natal closure of ductus arteriosus. Hepatotoxicity is the greatest fault of APAP and the most frequent cause of drug-induced acute liver failure in Western countries. However, its precise mechanism remains unclear and no effective cure beyond N-acetylcysteine has been developed. Recent animal and cellular studies have demonstrated that some cellular events, such as c-jun N-terminal kinase (JNK) pathway activation, endoplasmic reticulum (ER) stress, and mitochondrial oxidative stress may play important roles in the development of hepatitis. Herein, the molecular mechanisms of APAP hepatotoxicity are summarized. We also discuss the not-so-familiar "dark side" of APAP as an otherwise safe analgesic/antipyretic drug.

Language: en

Keywords

acetaminophen (APAP); drug-induced asthma; ductus arteriosus; endoplasmic reticulum stress; hepatotoxicity; mitochondria